ARTICLE | Company News
Andrulis Pharmaceuticals Corp., University of Verona deal
August 14, 1995 7:00 AM UTC
Andrulis and the University of Verona will study the ability of thalidomide to inhibit the production of cytokines by immune system cells of the brain. The Verona scientists hypothesize that inflammatory cytokines and free radicals may be responsible for the degeneration observed in Alzheimer's disease. ...